[HTML][HTML] Pathophysiology of acute myeloid leukemia

F Wachter, Y Pikman - Acta Haematologica, 2024 - karger.com
Background: Acute myeloid leukemia (AML) is a biologically heterogenous disease arising
in clonally proliferating hematopoietic stem cells. Sequential acquisition of mutations leads …

Mechanisms associated with t (7; 12) acute myeloid leukaemia: from genetics to potential treatment targets

D Ragusa, L Dijkhuis, C Pina, S Tosi - Bioscience Reports, 2023 - portlandpress.com
Acute myeloid leukaemia (AML), typically a disease of elderly adults, affects 8 children per
million each year, with the highest paediatric incidence in infants aged 0–2 of 18 per million …

Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t (14; 18) Translocation

E Garimberti, C Federico, D Ragusa, F Bruno… - International Journal of …, 2024 - mdpi.com
Chromosomal rearrangements have been shown to alter genome organization,
consequently having an impact on gene expression. Studies on certain types of leukemia …

Aberrant MNX1 expression associated with t (7; 12)(q36; p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation

A Waraky, A Östlund, T Nilsson, D Weichenhan… - …, 2023 - pmc.ncbi.nlm.nih.gov
Certain subtypes of acute myeloid leukemia (AML) in children have inferior outcome, such
as AML with translocation t (7; 12)(q36; p13) leading to an MNX1:: ETV6 fusion along with …

Robertsonian Translocation between Human Chromosomes 21 and 22, Inherited across Three Generations, without Any Phenotypic Effect

C Federico, D Brancato, F Bruno, D Galvano, M Caruso… - Genes, 2024 - mdpi.com
Chromosomal translocations can result in phenotypic effects of varying severity, depending
on the position of the breakpoints and the rearrangement of genes within the interphase …

Dissecting infant leukemia developmental origins with a hemogenic gastruloid model

D Ragusa, CW Suen, G Torregrosa-Cortés, F Pastorino… - bioRxiv, 2022 - biorxiv.org
Current in vitro models of developmental blood formation lack spatiotemporal coherence
and weakly replicate the hematopoietic microenvironment. Developmentally-appropriate …

Pathophysiology of Acute Myeloid Leukemia

F Wachter, Y Pikman - Acta Haematologica, 2024 - karger.com
Background: Acute myeloid leukemia (AML) is a biologically heterogenous disease arising
in clonally proliferating hematopoietic stem cells. Sequential acquisition of mutations leads …

Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including MNX1 activation via deletion 7q

E Sollier, A Riedel, UH Toprak, JA Wierzbinska… - bioRxiv, 2024 - biorxiv.org
Acute myeloid leukemia with complex karyotype (ckAML) is characterized by high genomic
complexity, including frequent TP53 mutations and chromothripsis. We hypothesized that the …

Mnx1 induces leukemia transformation through altering histone methylation in a model of pediatric t (7; 12) acute myeloid leukemia

A Waraky, A Östlund, T Nilsson, D Weichenhan… - Bior**v, 2022 - biorxiv.org
Acute myeloid leukemia (AML) in children with certain genetic aberrations is still associated
with inferior outcome. One of these AML subtypes has a translocation t (7; 12)(q36; p13) and …

Epigenetic compound screening in AML with MNX1 overexpression

S Kelekçi - 2024 - archiv.ub.uni-heidelberg.de
Acute myeloid leukemia (AML) is a form of blood cancer characterized by impaired
differentiation and accelerated proliferation due to (epi) genetic dysregulation of …